Perfuze Revenue and Competitors
Estimated Revenue & Valuation
- Perfuze's estimated annual revenue is currently $9.3M per year.
- Perfuze's estimated revenue per employee is $251,000
- Perfuze's total funding is $53M.
Employee Data
- Perfuze has 37 Employees.
- Perfuze grew their employee count by 16% last year.
Perfuze's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Co-founder | Reveal Email/Phone |
2 | CTO and Co-Founder | Reveal Email/Phone |
3 | Finance Director | Reveal Email/Phone |
4 | Clinical Technology Manager | Reveal Email/Phone |
5 | Clinical Affairs Manager | Reveal Email/Phone |
6 | Manufacturing Engineering Manager | Reveal Email/Phone |
7 | Quality Manager | Reveal Email/Phone |
8 | Manufacturing Engineer | Reveal Email/Phone |
9 | Design Assurance Engineer | Reveal Email/Phone |
10 | Quality engineer | Reveal Email/Phone |
Perfuze Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 211 | 12% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 64 | -7% | N/A | N/A |
#8 | $61.2M | 215 | 8% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Perfuze?
Neurovascular medtech startup
keywords:N/A$53M
Total Funding
37
Number of Employees
$9.3M
Revenue (est)
16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Perfuze News
2022-04-17 - Marginální dárci jsou tahouny moderní transplanta?ní ...
Marginální dárci jsou tahouny moderní transplanta?ní medicíny, pomáhají perfuze orgán?. 22.4.2022. Díky moderním technologiím a lék?m...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $6.9M | 39 | 26% | N/A |
#2 | $8.4M | 39 | 34% | N/A |
#3 | N/A | 40 | 43% | $25M |
#4 | $7.4M | 48 | 9% | N/A |
#5 | N/A | 49 | 48% | N/A |